Enews from the Alzheimer's Association

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.
September 7, 2016
24/7 Helpline: 800.272.3900
Experimental Alzheimer's drug shows promise against brain plaques
An experimental drug called aducanumab dramatically reduced the toxic plaques found in the brains of people living with Alzheimer's disease, according to results of a Phase1b clinical trial designed to test safety and tolerability rather than effectiveness. The results, previously reported at the Alzheimer’s Association International Conference® 2015 (AAIC®), hinted that the drug may also be able to slow the loss of memory and thinking. Experts caution that additional, larger studies will be necessary to determine if aducanumab has an effect on slowing down Alzheimer’s.

Click here to read more
Alzheimer's disease may have an effect on your relationships
While your abilities may change over time with Alzheimer’s, how you continue to be a partner in your relationships can impact your ability to live well with the disease. Establishing and maintaining meaningful relationships throughout your Alzheimer's experience can enhance your ability to stay both physically and emotionally healthy.
Click here to read more
Online Tools
Your Local Community
 
 
Repetitive behavior may be stressful for Alzheimer’s caregivers
A person with Alzheimer's may do or say something over and over — like repeating a word, question or activity — or undo something that has just been finished. Repetition can be stressful for the caregiver, but remember that it’s the disease causing the behavior, not the person.
Click here to read more
Your donations and support make a difference.
More Resources: 
Behaviors  | 
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.

Alzheimer's Association National Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2016 Alzheimer's Association. All rights reserved. www.alz.org | 800.272.3900
To change your email preferences click here.